Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (1,300) Arrow Down
Filter Results: (1,300) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (1,300)
    • People  (4)
    • News  (228)
    • Research  (904)
    • Events  (4)
    • Multimedia  (7)
  • Faculty Publications  (497)

Show Results For

  • All HBS Web  (1,300)
    • People  (4)
    • News  (228)
    • Research  (904)
    • Events  (4)
    • Multimedia  (7)
  • Faculty Publications  (497)
← Page 3 of 1,300 Results →
  • December 2020
  • Article

Multinational Firms and the Politics of International Trade in Multidisciplinary Perspective

By: Grace A. Ballor and Aydin B. Yildirim
From the technical analyses of wide ranges of scholars to the public discourse backlashes against globalization, there is a huge volume of work historicizing, quantifying, and problematizing the complex role of multinational corporations (MNCs) in international trade.... View Details
Keywords: Multinational Corporations; International Trade; Big Business; Economic Governance; Global Value Chains; Trade Policy; Corporate Regulation; Multinational Firms and Management; Trade; Policy; Governance; Globalization
Citation
Find at Harvard
Read Now
Related
Ballor, Grace A., and Aydin B. Yildirim. "Multinational Firms and the Politics of International Trade in Multidisciplinary Perspective." Special Issue on Multinational Corporations and the Politics of International Trade. Business and Politics 22, no. 4 (December 2020): 573–586.
  • 1999
  • Chapter

Multinational Cross-Investment between Switzerland and Britain 1914-1945

By: G. Jones
This chapter examines multinational cross-investment between Switzerland and Great Britain between 1914 and 1945. While Great Britain and Switzerland were both major home economies for multinationals,few companies from either country were interested in investing in the... View Details
Keywords: History; Multinational Firms and Management; International Relations; Investment; Great Britain; Switzerland
Citation
Related
Jones, G. "Multinational Cross-Investment between Switzerland and Britain 1914-1945." In Switzerland and the Great Powers 1914-1945, edited by Sebastien Guex. Geneva: Librairie Droz, 1999.
  • 10 Jul 2006
  • Working Paper Summaries

Nationality and Multinationals in Historical Perspective

Keywords: by Geoffrey G. Jones
  • 02 Sep 2002
  • Research & Ideas

Foreign Multinationals in the U.S.: A Rocky Road

What can companies today take away from the experience of myriad multinationals in the United States? A lot, says HBS professor Geoffrey G. Jones, a specialist in business history and international business.... View Details
Keywords: by Sarah Jane Johnston & Martha Lagace
  • May 2016
  • Case

AbbVie

By: Kevin Schulman, Laura Little, Samyukta Mullangi and Stephen Schleicher
This case focuses on the impact of a novel regulatory pathway, the biosimilars pathway, on the strategy of a major pharmaceutical firm that finds its largest product (60% of revenue) at risk. The case reviews the rationale for the pathway, the emerging biosimilars... View Details
Keywords: Pharmaceutical Company; M&A Valuation; AbbVie; Health Care; Health Care and Treatment; Pharmaceutical Industry; Pharmaceutical Industry; United States
Citation
Educators
Purchase
Related
Schulman, Kevin, Laura Little, Samyukta Mullangi, and Stephen Schleicher. "AbbVie." Harvard Business School Case 316-095, May 2016.
  • May 2011
  • Case

The Morrison Company

By: Steven C. Wheelwright and Paul Meyers
The Morrison Company develops and manufactures radio frequency identification tags (RFID) known as smart labels for the retail and pharmaceutical industries. RFID technology is a fast-growing and increasingly competitive industry. Sales have risen dramatically over the... View Details
Keywords: Quantitative Analysis; Technology; Operations Management; Product Lines; Manufacturing; Capacity Planning; Production Planning; Information Technology; Strategy; Production; Organizational Structure; Infrastructure; Product Development; Information Infrastructure; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Wheelwright, Steven C., and Paul Meyers. "The Morrison Company." Harvard Business School Brief Case 114-564, May 2011.
  • 01 Mar 2007
  • News

Daniel Vasella

portfolio of product lines, setting Novartis apart from its global competitors. Although initially regarded by critics as too inexperienced to lead a multinational pharmaceutical company, Vasella has... View Details
Keywords: Roger Thompson; multinational pharmaceutical company; prescription drugs; vaccines; Medicare; generics business; Health, Social Assistance
  • January 2018
  • Supplement

BeiGene Supplemental PowerPoint

By: Willy C. Shih and Jimmy Zhang
BeiGene was a biopharmaceutical company founded on exploiting a temporal regulatory policy discontinuity. Because of regulatory challenges in China, most innovative new drugs launched there four to six years after their initial U.S. launches. This gave BeiGene a window... View Details
Keywords: Biotechnology; Pharmaceutical Company; Pharmaceuticals; China; Regulatory Environment; Business Strategy; Innovation Strategy; Situation or Environment; Pharmaceutical Industry; Pharmaceutical Industry; China
Citation
Purchase
Related
Shih, Willy C., and Jimmy Zhang. "BeiGene Supplemental PowerPoint." Harvard Business School PowerPoint Supplement 618-043, January 2018.
  • 14 Mar 2014
  • HBS Seminar

Jeremy M. Levin, former President and CEO, Teva Pharmaceutical Industries

  • August 2001
  • Case

Pharmaceutical Industry and the AIDS Crisis in Developing Countries, The

Explores the controversy over the pricing of AIDS drugs in poor countries. This issue has received wide publicity due to two events: 1) a court case in South Africa that seeks to force drug companies to license their patents and 2) the announcement by the Indian... View Details
Keywords: Competition; Developing Countries and Economies; Business and Government Relations; Pharmaceutical Industry; South Africa; India
Citation
Educators
Purchase
Related
Kennedy, Robert E. "Pharmaceutical Industry and the AIDS Crisis in Developing Countries, The." Harvard Business School Case 702-010, August 2001.
  • 12 Mar 2014
  • Research & Ideas

Entrepreneurship and Multinationals Drive Globalization

company Beiersdorf is the most dramatic. Beiersdorf faced the worst of all worlds in terms of political risk. It was a determined multinational investor before World War I, and then lost everything as the... View Details
Keywords: by Sean Silverthorne; Pharmaceutical; Pharmaceutical; Pharmaceutical; Pharmaceutical
  • 01 Nov 2013
  • HBS Seminar

Eric Olson, Chief Scientific Officer at Syros Pharmaceuticals

  • 27 Jan 2011
  • News

The Gender Advantage for Multinational Firms

  • July 2003 (Revised August 2003)
  • Case

Lamoiyan Corporation of the Philippines: Challenging Multinational Giants

A local Philippine toothpaste manufacturer, Lamoiyan Corp., faces the challenge of staying competitive against entrenched multinational giants. The company has managed to capture, at its peak, 20% of the Philippine toothpaste market and has become the number three... View Details
Keywords: Multinational Firms and Management; Competitive Strategy; Emerging Markets; Entrepreneurship; Consumer Products Industry; Philippines
Citation
Educators
Purchase
Related
Coughlan, Peter J., and Jenny Illes. "Lamoiyan Corporation of the Philippines: Challenging Multinational Giants." Harvard Business School Case 704-405, July 2003. (Revised August 2003.)
  • January 1994
  • Article

Foreign Multinationals in British Manufacturing, 1850-1962

By: G. Jones and Frances Bostock
This article draws on a new database to describe the dimensions and characteristics of 685 foreign companies which established British manufacturing subsidiaries between 1850 and 1962. The numbers of foreign companies grew from the 1890s, expanded rapidly in the... View Details
Keywords: Multinational Firms and Management; Business Subsidiaries; Expansion; Chemicals; Metals and Minerals; Food; Mergers and Acquisitions; Market Entry and Exit; Research and Development; Trade; Investment; Production; United Kingdom; United States; Scotland; Wales
Citation
Find at Harvard
Related
Jones, G., and Frances Bostock. "Foreign Multinationals in British Manufacturing, 1850-1962." Business History 36, no. 1 (January 1994): 89–126.
  • October 2007 (Revised July 2013)
  • Case

Vertex Pharmaceuticals and the Cystic Fibrosis Foundation: Venture Philanthropy Funding for Biotech

By: Robert F. Higgins, Sophie LaMontagne and Brent Kazan
In 2001, Vertex Pharmaceuticals Incorporated acquired the San Diego-based biotech company, Aurora Biosciences. The combination of Vertex's and Aurora's technologies would improve the flow of novel drug candidates into development. However, several questions related to... View Details
Keywords: Philanthropy; Philanthropy Funding; Innovation; Funding Model; Venture Capital; Partners and Partnerships; Financing and Loans; Investment Funds; Acquisition; Philanthropy and Charitable Giving; Pharmaceutical Industry; Pharmaceutical Industry; San Diego
Citation
Educators
Purchase
Related
Higgins, Robert F., Sophie LaMontagne, and Brent Kazan. "Vertex Pharmaceuticals and the Cystic Fibrosis Foundation: Venture Philanthropy Funding for Biotech." Harvard Business School Case 808-005, October 2007. (Revised July 2013.)
  • June 2002 (Revised November 2005)
  • Case

Life, Death, and Property Rights: The Pharmaceutical Industry Faces AIDS in Africa

By: Debora L. Spar
In the final years of the 20th century, the world was hit by a plague of epidemic proportions--AIDS, a life-threatening disease that remained stubbornly immune to any cure or vaccine. In the developed nations of the West, AIDS was slowly brought under control through a... View Details
Keywords: Patents; Health Pandemics; Corporate Social Responsibility and Impact; Pharmaceutical Industry; Africa
Citation
Educators
Purchase
Related
Spar, Debora L., and Nick Bartlett. "Life, Death, and Property Rights: The Pharmaceutical Industry Faces AIDS in Africa." Harvard Business School Case 702-049, June 2002. (Revised November 2005.)
  • June 2017
  • Supplement

Transformation at Eli Lilly & Co. (C)

By: William R. Kerr and Alexis Brownell
Keywords: Eli Lilly; Pharmaceutical Companies; Restructuring; Organizational Change and Adaptation; Pharmaceutical Industry; Indiana; Indianapolis
Citation
Purchase
Related
Kerr, William R., and Alexis Brownell. "Transformation at Eli Lilly & Co. (C)." Harvard Business School Supplement 817-137, June 2017.
  • 08 Dec 2003
  • Research & Ideas

Why Europe Lags in Pharmaceuticals and Biotech

Bastianelli, vice president of corporate development at ProSkelia Pharmaceuticals in France. Once companies are created, there is little incentive to improve, he said, and labor laws make it difficult to... View Details
Keywords: by Sean Silverthorne; Pharmaceutical; Pharmaceutical; Pharmaceutical; Pharmaceutical
  • June 1991
  • Case

Eli Lilly and Co.: European Pharmaceutical Operations

By: Michael Y. Yoshino
Keywords: Multinational Firms and Management; Pharmaceutical Industry; Europe
Citation
Find at Harvard
Related
Yoshino, Michael Y. "Eli Lilly and Co.: European Pharmaceutical Operations." Harvard Business School Case 391-234, June 1991.
  • ←
  • 3
  • 4
  • …
  • 64
  • 65
  • →
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.